When Should TSH Testing Be Performed?
TSH testing should be performed when patients have signs or symptoms of thyroid dysfunction, but routine screening of asymptomatic adults is not recommended due to insufficient evidence of benefit and potential harms from overdiagnosis and overtreatment. 1
Screening in Asymptomatic Adults
The USPSTF concludes there is insufficient evidence to recommend for or against routine TSH screening in asymptomatic, nonpregnant adults. 1
Screening asymptomatic adults does not improve quality of life, blood pressure, BMI, bone mineral density, lipid levels, or cognitive function over 1-2 years of follow-up. 1
The harms of screening asymptomatic individuals include frequent false-positive results, psychological effects of labeling, and substantial overdiagnosis and overtreatment, particularly when TSH levels are less than 10 mIU/L. 1
If clinicians choose to screen asymptomatic patients, they must first ensure patients understand the uncertainties surrounding potential benefits and the possibility of harm. 1
Diagnostic Testing in Symptomatic Patients
TSH is the preferred initial test when thyroid dysfunction is clinically suspected based on signs or symptoms. 2, 3
The sensitive TSH assay is the single best screening test for both hyperthyroidism and hypothyroidism in most outpatient clinical situations. 3
If TSH is abnormal, obtain free T4 to further narrow the diagnosis. 2
If TSH is undetectable and free T4 is normal, obtain a T3 level. 2
Confirmation and Follow-up Testing
Abnormal TSH results in asymptomatic individuals should be repeated for confirmation before diagnosis or treatment, unless TSH is >10.0 or <0.1 mIU/L. 1
For TSH between 0.1-0.45 mIU/L: Repeat within 2 weeks if atrial fibrillation, cardiac disease, or serious medical conditions are present; otherwise repeat within 3 months. 4
For TSH <0.1 mIU/L: Repeat within 4 weeks along with free T4 and total T3 or free T3. If cardiac disease, atrial fibrillation, or hyperthyroid symptoms are present, test sooner. 4
Repeat testing at 3-6 month intervals is recommended to confirm persistent dysfunction before initiating treatment strategies. 1
Monitoring Established Thyroid Disease
TSH is the most important parameter for monitoring adequacy of replacement therapy in primary hypothyroidism. 2
For central hypothyroidism, TSH cannot be used for monitoring; use free T4 and T3 concentrations instead. 2
In patients with Graves' disease on antithyroid drugs, TSH may remain low for months after achieving euthyroid status, and free T4 may drop below normal while T3 remains elevated. 5
Important Timing Considerations
TSH levels fluctuate significantly during the day, decreasing from 7 AM to 1 PM and increasing from 1 PM to 4 PM, with deviations up to -24.53%. 6
Standardize the time of sample collection for TSH measurements to ensure accurate monitoring and comparison. 6
Free T4 and free T3 do not exhibit clinically significant circadian variation. 6
Common Pitfalls to Avoid
Do not diagnose or treat based on a single abnormal TSH result in asymptomatic patients, as TSH secretion is sensitive to conditions other than thyroid dysfunction and has significant measurement variability. 1
Be aware that age-specific reference intervals are important; TSH upper limits increase after age 50-60 years, and using standard adult ranges can lead to overdiagnosis of subclinical hypothyroidism in older adults. 7
Laboratory reference intervals are based on statistical distribution rather than association with symptoms or adverse outcomes, leading to professional disagreement about appropriate cutoff points. 1